by Dr. Raymond Singer | Jul 10, 2025 | health
GLP‑1 receptor agonists — including Ozempic, Wegovy, Mounjaro, and Zepbound — have had a transformative impact on obesity management in the United States. Following a threefold increase in adult obesity rates from 1960 to 2021, recent U.S. health data now shows a...